Literature DB >> 9729511

Functional activity of epidermal growth factor receptors in autosomal recessive polycystic kidney disease.

W E Sweeney1, E D Avner.   

Abstract

Evidence from a number of laboratories suggests a potential role for the epidermal growth factor (EGF)-transforming growth factor-alpha-epidermal growth factor receptor (EGF-R) axis in promoting epithelial hyperplasia and cyst formation in autosomal recessive polycystic kidney disease (ARPKD). As previously reported, in the C57BL-6Jcpk/cpk (CPK), BALB/c-bpk/bpk (BPK), and C3H-orpk/orpk (ORPK) murine models of ARPKD, as well as in human ARPKD and human ADPKD, the EGF-R is mislocated to the apical surface of cystic collecting tubule (CT) epithelial cells. The present studies demonstrate that cells from cystic and control CTs can be isolated and that these cells maintain their in vivo EGF-R phenotype in vitro. Domain-specific high-affinity ligand binding was assessed by standard Scatchard analysis, and selective ligand stimulation of apical vs. basolateral EGF-R in these cells was followed by measurement of receptor autophosphorylation and determination of cell proliferation. These studies demonstrate that in vitro apically expressed EGF-Rs exhibit high-affinity binding for EGF, autophosphorylate in response to EGF, and transmit a mitogenic signal when stimulated by the appropriate ligand.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9729511     DOI: 10.1152/ajprenal.1998.275.3.F387

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  24 in total

1.  ErbB4 modulates tubular cell polarity and lumen diameter during kidney development.

Authors:  Ville Veikkolainen; Florence Naillat; Antti Railo; Lijun Chi; Aki Manninen; Peter Hohenstein; Nick Hastie; Seppo Vainio; Klaus Elenius
Journal:  J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 10.121

Review 2.  Epigenetics and autosomal dominant polycystic kidney disease.

Authors:  Xiaogang Li
Journal:  Biochim Biophys Acta       Date:  2010-10-20

Review 3.  Potential pharmacological interventions in polycystic kidney disease.

Authors:  Amirali Masoumi; Berenice Reed-Gitomer; Catherine Kelleher; Robert W Schrier
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 4.  Regulation of transport in the connecting tubule and cortical collecting duct.

Authors:  Alexander Staruschenko
Journal:  Compr Physiol       Date:  2012-04       Impact factor: 9.090

5.  Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease.

Authors:  Fangming Lin; Thomas Hiesberger; Kimberly Cordes; Angus M Sinclair; Lawrence S B Goldstein; Stefan Somlo; Peter Igarashi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-02       Impact factor: 11.205

Review 6.  Diagnosis, pathogenesis, and treatment prospects in cystic kidney disease.

Authors:  Carsten Bergmann; Valeska Frank; Fabian Küpper; Dirk Kamitz; Jens Hanten; Peter Berges; Silke Mager; Markus Moser; Jutta Kirfel; Reinhard Büttner; Jan Senderek; Klaus Zerres
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

7.  Receptor protein tyrosine phosphatases are novel components of a polycystin complex.

Authors:  Catherine A Boucher; Heather H Ward; Ruth L Case; Katie S Thurston; Xiaohong Li; Andrew Needham; Elsa Romero; Deborah Hyink; Seema Qamar; Tamara Roitbak; Samantha Powell; Christopher Ward; Patricia D Wilson; Angela Wandinger-Ness; Richard N Sandford
Journal:  Biochim Biophys Acta       Date:  2010-11-29

8.  Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium.

Authors:  Tengis S Pavlov; Daria V Ilatovskaya; Oleg Palygin; Vladislav Levchenko; Oleh Pochynyuk; Alexander Staruschenko
Journal:  J Vis Exp       Date:  2015-09-01       Impact factor: 1.355

9.  Src inhibition ameliorates polycystic kidney disease.

Authors:  William E Sweeney; Rodo O von Vigier; Philip Frost; Ellis D Avner
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

10.  Acceleration of polycystic kidney disease progression in cpk mice carrying a deletion in the homeodomain protein Cux1.

Authors:  Neal I Alcalay; Madhulika Sharma; Dianne Vassmer; Brandon Chapman; Binu Paul; Jing Zhou; Jennifer G Brantley; Darren P Wallace; Robin L Maser; Gregory B Vanden Heuvel
Journal:  Am J Physiol Renal Physiol       Date:  2008-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.